Xu Li

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 4

Top Topics

Anti Inflammatory

Top Venues

ACS applied materials & interfaces

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Li, Solange A Valdes, Riyad F Alzhrani, Stephanie Hufnagel, Stephen D Hursting, Zhengrong Cui
Zoledronic Acid-containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor. ACS applied materials & interfaces 11 (7) (2019)
Hannah L O'Mary, Abdulaziz M Aldayel, Solange A Valdes, Youssef W Naguib, Xu Li, Karun Salvady, Zhengrong Cui
Acid-Sensitive Sheddable PEGylated, Mannose-Modified Nanoparticles Increase the Delivery of Betamethasone to Chronic Inflammation Sites in a Mouse Model. Molecular pharmaceutics 14 (6) (2017)
Xu Li, Stephanie Hufnagel, Haiyue Xu, Solange A Valdes, Sachin G Thakkar, Zhengrong Cui, Hugo Celio
Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity. ACS applied materials & interfaces 9 (27) (2017)
Xu Li, Youssef W Naguib, Solange Valdes, Stephanie Hufnagel, Zhengrong Cui
Reverse Microemulsion-Based Synthesis of (Bis)phosphonate-Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid-Calcium Complexes. ACS applied materials & interfaces 9 (16) (2017)